![Addressing the yearly $53B problem for pharma companies using groundbreaking AI and ‘Patient- on-a-chip’ technology](https://industry.pharmafocusasia.com/slider/1719490827-addressing-the-yearly-01.png)
Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG
IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug
Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated
Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta
Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A
BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics
Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness over to years if left untreated Like Alzheimers...
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic
ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed
NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate
Boston, MA, USA
jakarta barat, Indonesia
Jakarta Barat, Indonesia
Songdo Convensia, Incheon, South Korea
Songdo Convensia, Incheon, South Korea
Lisbon, Portugal
London, UK
Senior Associate, Medicinal Products Division, Freyr Solutions
Senior Consultant, Process Solutions APAC, Life Science business sector of Merck
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology
School of Life Sciences, Lanzhou University, Gansu Province, China
Department of Microbiology, Khyber Medical University Peshawar, Pakistan
School of Stomatology, Northwest Minzu University, Lanzhou, Gansu, China
Gansu Public Provincial Hospital, Gansu Province, China
Department of Microbiology, Khyber Medical University Peshawar, Pakistan
School of Life Sciences, Lanzhou University, Gansu Province, China
Lanzhou University Second Hospital, Gansu Province, China
Associate Professor, Department of Biology, Khalifa University
Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University andhas previously chaired multiple researchadministrative committees He has been heavilyinvolved in multiple programs for training graduate clinical embryology students Dr Kashirsresearch aims to develop therapeuticdiagnostic interventions to treat infertility and understandembryologyRegulatory affairs in the pharmaceutical industry encompass a broad and complex field that is essential for the development approval and postmarketing surveillance of pharmaceutical products This domain acts as the critical nexus between pharmaceutical companies
Antibiotic resistance ABR has substantial global public health concerns This systematic review aimed to synthesise recent evidence estimating the economic burden of ABR characterised by study perspectives healthcare settings study design and income of the countries
AbstractGMgangliosidosis is a rare lysosomal storage disorder characterized clinically by a wide range of variable neurovisceral ophthalmological and dysmorphic features Without enough functional galactosidase GMgangliosides cannot be degraded in lysosomes and accumulate to toxic levels in many tissues and organs particularly in the brain In s
Orchard Therapeutics has unveiled its groundbreaking treatment Lenmeldy as the first and only approved therapy designed for children afflicted with earlyonset metachromatic
SummaryMultitip punches increase the number of tablets produced per turret rotation which increases production rates of existing presses Steve Osborn product design manager at tablet tooling manufacturer I Holland spoke to Pharmaceutical Technology Europe about the key considerations for successful implementation of multitip tooling in tableting operatio
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster